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Kinetic adsorptionical experimental study of the adsorption of colloids onto the plasma membrane
of living cells mediated by speciﬁc ligand–receptor interactions. The colloids consist of lipid multilamellar
liposomes (spherulites) functionalized by Shiga toxin B-subunit (STxB), while cells are cervix carcinoma
epithelial cells expressing the Shiga toxin receptor, the glycolipid globotriaosyl ceramide (Gb3). The
speciﬁcity of the colloid adsorption is demonstrated using both confocal microscopy and ﬂow cytometry,
while a thorough cytometry study on living cells allows characterizing the kinetics of this speciﬁc adsorption.
The ﬁnal number of bound colloids and the characteristic adsorption time are shown to depend on bulk
concentration, as expected for a thermodynamic equilibrium. However, the colloids appear to be irreversibly
attached to the membrane. We interpret this apparent irreversibility as the result of a progressive
recruitment of receptors. The methodology used here, whereby microscopic mechanisms are deduced from
direct quantitative measurements on living cells, might allow the optimization of drug delivery systems or
the quantiﬁcation of virus infectivity.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionViruses infecting a cell or artiﬁcial particles delivering drugs into a
speciﬁc tissue are situations where a suspension of freely diffusing
objects interacts with a cell membrane. The ﬁrst step of this
interaction is the binding of the colloid onto the membrane, and
usually depends on the high afﬁnity between two complementary
molecules, either proteins or lipids [1]. This so called ligand/receptor
interaction allows for the speciﬁc recognition between the virus and
the host cell, or a particle and a targeted tissue, and triggers a complex
succession of events: particle docking, membrane wrapping, endocy-
tosis or fusion, and subsequent intracellular trafﬁcking. Because the
mechanisms involved in the early stages of these processes are
essential for modern drug delivery applications [2] as well as virology
[3], biologists, biochemists along with biophysicists have devoted
considerable efforts in recent years to better understand them. While
many cell biology studies were interested in events at the cellular
scale, and structural studies focused on themolecular scales, we chose
here an intermediate approach where the binding step is quantiﬁed
directly on living cells.
Most quantitative experiments in cell biology involving particle
internalization measure a global response, the biological effect of theex 1, France.
ier@fr.netgrs.com (C. Poirier).
ll rights reserved.active compound in the case of drug delivery or the multiplication of
the viruses in the case of virology [4]. These methods integrate the
whole path, from particle binding up to the efﬁciency of the local
release and subsequent activity of the content (in the case of drug
delivery) or up to replication and subsequent budding (in the case of
viruses). In these scenarii, it is difﬁcult to obtain quantitative
information about the different steps. Another approach is to
characterize quantitatively the ligand/receptor interaction on the
molecular level. Structural studies extract the detailed molecular basis
of the interactionwhile biochemical tools allow for themeasurements
of association constants as well as association and dissociations rate
constants [5,6]. More recently, to measure the energy of rupture of
such single speciﬁc bonds, biophysical techniques have been devel-
oped such as the Bio Force Probe [7,8] or adapted from existing tools
such as Atomic Force Microscopy [9,10]. In these cases, the molecular
link is studied in a geometry that does not correspond to the actual
cellular situation where the ligand is exposed on the surface of the
particle and the receptor is immersed in the cell membrane. Aspects
such as the ability of receptors to freely diffuse in the membrane and
the multiplicity of binding sites are thus neglected, despite the fact
that they are key features involved in the overall adhesion energy. This
is known from usual cell adhesionwhere the cell membrane binds to a
substrate bearing ligands and has been studied over the years by
physicists and biologists both theoretically [11–13] and experimen-
tally [14–16]. In many respects, the adsorption of a suspension of
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of cell adhesion. The main physical difference is that here colloids
interact independently with the cell, whereas on a solid substrate, all
the ligands are initially available.
In the intermediate approach presented here, which keeps the
complexity of the cell but deals speciﬁcally with the adhesion step, we
build up a controlled system involving submicron sized particles,
namely spherulites, functionalized with a ligand, namely Shiga toxin
B-subunit (STxB). Spherulites are multilamellar lipidic vesicles able to
encapsulate biomolecules [17,18], that could potentially be used as
carriers for drug delivery [19]. When these particles are charged
(owing to the addition of a fraction of positively charged lipids), their
binding to cells is mediated by electrostatic interactions and is shown
to be non-speciﬁc and reversible [20]. When neutral but functiona-
lized by an RGD-containing peptide on their surface, they were shown
to target integrins and be speciﬁcally captured by adherent cells [21].
STxB is known to bind the glycosphingolipid globotriaosyl ceramide
(Gb3), a receptor over-expressed in various human tumors, and to
enter the cytoplasm via the retrograde route. After endocytosis, the
retrograde route allows the trafﬁcking of STxB from endosomes to the
Golgi apparatus and the endoplasmic reticulum directly, bypassing the
degrading environment of late endosomes/lysosomes and recycling to
the plasma membrane [22,23]. The mechanism involved in this
internalization has recently been clariﬁed [24]. This protein fragment
has been identiﬁed as a promising tool for drug-targeting and was
proposed so far for direct coupling with therapeutic agents [25,26].
Using STxB-functionalized spherulites (called STxB-spherulites)
interacting with HeLa cells of epithelial origin that express the Shiga
toxin receptor Gb3, the present study describes how a population of
Brownian colloidal particles can interact with cell receptors. We ﬁrst
demonstrate the speciﬁcity of the interaction through confocal
microscopy and ﬂow cytometry. Then we show how ﬂow cytometry
measurements allow characterizing the adhesion step through
statistical measurements of the kinetics on a population of cells
with a population of particles. By studying the kinetics of the
adsorption for different colloid concentrations, we show the existence
of an apparent irreversibility. We ﬁnally discuss the underlying
mechanisms that could possibly be involved.
2. Materials and methods
2.1. Shiga toxin B-subunit
Shiga toxin B-subunit (STxB) bearing a C-terminal cysteine (Cys)
was obtained as described previously [27]. The reactive hydrosulfur of
the cysteine group allows easy and efﬁcient coupling reactions. A
6 mg/mL stock solution of STxB/Cys in Hepes buffer (pH=7.4) is then
stored at −80 °C until use. A ﬂuorescent STxB variant was prepared by
coupling STxB/Cys to a ﬂuorescent FITC-maleimide (Molecular Probes-
F150), and eliminating unbound ﬂuorophores with a sephacryl
column (G25), following the manufacturer's instructions.
2.2. Multilamellar colloids
Phosphatidylcholine puriﬁed from soybean lecithinwas purchased
from Lipoid, 1,2-Dioleoyl-sn-Glycero-3-phosphoethanolamine-N-[4-
(p-maleimidomethyl)cyclohexane carboxamide] (named maleimide
anchor) and Bodipy-FL C12-HPC ((4, 4-diﬂuoro-5,7-dimethyl-4-bora-
3a, 4a-diaza-s-indacene-3-dodecanoyl)-1-hexadecanoyl-sn-glycero-
3-phosphocholine) (named bodipy lipid) from Avanti Polar Lipids.
2.3. Preparation of spherulites
Spherulites are prepared by shearing a lamellar phase made of
lipids and water, following the process described previously [21] and
brieﬂy summarized here. The lipids, 93% (w:w) phosphatidylcholine,7% maleimide anchor, and 0.1% bodipy lipid for ﬂuorescence (Ex. 488
nm, Em. 512 nm), are dissolved and mixed into an ethanol/chloroform
solution (50/50 v/v). After evaporation, a homogeneous ﬁlm of lipids is
obtained, which is then hydrated with 48% (w:w) water to form a
lamellar phase, and sheared to obtain an onion-like texture. The
addition of a large excess of PBS buffer (25/1 v/v) ﬁnally leads to a 40
mg/mL solution of spherulites. At the end of the process, we obtain
ﬂuorescent colloids, having a mean diameter of approximately 200
nm (±80 nm) as measured by light scattering [21], and bearing
reactive maleimide functions on their surface.
2.4. Functionalization of spherulites
The covalent grafting of STxB is performed by adding STxB/Cys
stock solutions (1/3 v/v) to the colloidal dispersion and letting the
coupling reaction proceed overnight at room temperature under
gentle stirring. Gel ﬁltration on a S300HR column (Amersham) is
performed to separate conjugated-spherulites from free STxB. After
ﬁltration, the resulting colloid concentration is deduced from a pre-
established ﬂuorescence abacus. Spherulites functionalized with
STxB are then obtained with a ligand surface density evaluated to
be of the order of 2.10− 2/nm2. Independently from the experiments
on cells, the coupling reaction was characterized by labeling directly
a suspension of particles through immunoﬂuorescence and Western-
blotting with a monoclonal antibody against STxB (data not shown).
In the following sections, the colloid concentration is given either in
mg/mL which corresponds to the spherulites lipid concentration or
in mol/L (M) which corresponds to the approximative number of
particles per volume when assuming monodispersity for the colloid
size.
2.5. Cell culture
HeLa cells are grown in Dulbecco's Modiﬁed Eagle's medium
(DMEM) supplemented with 10% fetal calf serum, 25 U/mL penicillin
and 25 μg/mL streptomycin. When needed, 5 μM of the glycosyl
ceramide synthase inhibitor 1-phenyl-2-hexadecanoyl-amino-3-mor-
pholino-1-propanol (PPMP) is added to the culture medium 5days
before the experiment to reduce the expression of glycolipids [22]. For
experiments using suspended cells, adherent cells are harvested from
their support just before the experiment with a 0.25% trypsin solution
(PBS) at 37 °C for 4 min, and washed twice in fresh DMEM (serum free
and phenol red free) with 10min, 400×g, 4 °C centrifugation. The
concentration is adjusted at 106 cells/mL, and cells are placed either on
ice at 4 °C for binding experiments, or at 37 °C to follow
internalization.
2.6. Data acquisition
Both confocalmicroscopy and ﬂuorescence cytometrywere carried
out to characterize particle adhesion on cells. Qualitative observations
were performed using a Leica TCS-SP2 confocal inverted microscope,
through a high numerical aperture oil objective lens (1.4) and by
means of the 488 nm excitation ray of an Argon laser. Quantitative
measurements were carried out using a FacsCalibur cytometer
equipped with an Argon laser (488 nm). Using forward and side
scattering parameters, the cell population of interest is gated (using
Cell Quest Pro software), allowing to exclude multiple cell events or
cellular fragments from the statistics. For each sample, at least 10,000
events are counted. On the gated area, cell population measurements
give rise to ﬂuorescence distributions. The ﬂuorescence of each cell is
directly proportional to the number of ﬂuorescent colloids bound to
the cell surface. Themean ﬂuorescence intensity of the cell population
is ﬁnally deduced from the mean geometric value of the lognormal
distribution. The background ﬂuorescence (intensity measured at
time of contact) is subtracted.
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The contact between the colloidal suspension and cells can be
done either on adherent cells for direct microscope observations or on
suspended cells for both ﬂuorescence cytometry measurements and
microscope observations. Colloids are added to the medium at a given
concentration, and are gently stirred to get a homogeneous mixture of
colloids and cells in the case of suspended cells. After a given
incubation time, in the case of adherent cells, wells are rinsed in order
to get rid of the excess of bulk ﬂuorescent particles, whereas
suspended cells are directly analyzed by ﬂow cytometry without any
further treatment, except when explicitly speciﬁed. This point is
important when dealing with equilibrium process.
3. Results
Our results can be divided in two parts. First, we show that STxB-
spherulite particles bind to the cell surface, and that this binding is
mediated through speciﬁc ligand/receptor recognition. Second, we
present the kinetics of STxB-spherulite adhesion onto the cell surface
and show that this adhesion process is irreversible, involving
numerous receptors. We then compare this result to the case of free
STxB.
3.1. Binding and speciﬁcity
Efﬁcient binding and internalization of STxB-spherulites on HeLa
cells expressing Gb3 was observed. Qualitative confocal ﬂuorescent
microscope observations are shown in Fig. 1. HeLa cells were
incubated for 2 h at 37 °C with a 0.5 mg/mL solution of STxB-
spherulites. Image a) shows adherent cells whereas image b) shows a
confocal section at the equatorial plane of suspended cells. We clearly
see that the ﬂuorescent particles are bound to cells and have been
internalized, the ﬂuorescent lipid probe being now localized in
intracellular compartments. The equatorial cut of a suspended cell isFig. 1. Confocal ﬂuorescence microscope images of HeLa cells incubated for 2 h with 0.5 m
Adherent cells at 37 °C; (b) Confocal equatorial cut of suspended cells at 37 °C (with closer
expression (PPMP, 5 μM), the speciﬁc receptor of STxB, together with the corresponding pha
cells at 4 °C (with closer view in insert at 1mg/mL). The ﬂuorescence signal of non-functionalstraightforward evidence that particles are inside cells. To address the
question of the speciﬁcity of recognition between STxB-spherulites
and the cell membrane, we analyzed non-functionalized spherulite
binding to Gb3-expressing cells (not shown), and STxB-spherulite
binding to Gb3 deﬁcient cells (Fig. 1c). The latter condition is obtained
by treating HeLa cells with the glucosylceramide synthase inhibitor
PPMP to reduce cellular Gb3 to levels below 5% [22]. The correspond-
ing phase contrast image of cells demonstrating that the morphology
of cells is intact after PPMP treatment is also shown. In both cases, we
observe a much weaker ﬂuorescence signal, indicating a smaller
amount of bound particles. Finally, cells shown in Fig. 1d were
incubated with STxB-spherulites at 4 °C. Particles remain bound to the
cell surface and do not penetrate into the cell.
To quantify these differences, we have performed ﬂow cytometry
measurements. Control and PPMP-treated cells were incubated with
the same volume fraction of ﬂuorescent STxB-colloids, and binding
kinetics were followed by ﬂow cytometry at 4 °C. We observed
classical adsorption curves leading to saturation plateau, whose values
are displayed in Fig. 2a. Fig. 2b shows complete kinetics at 4 °C. Colloid
adhesion is more than six fold lower in the case of PPMP-treated cells,
when compared to control cells, conﬁrming that Gb3 is required for
the adhesion of STxB-colloids. Secondly, the absence of ligands on the
colloid surface leads to a similar decrease in binding events. These
values can be considered as a non-speciﬁc adhesion background, and
we conclude that STxB-spherulite binding to cells is mediated by
speciﬁc ligand–receptor recognition.
3.2. Adhesion kinetics: determination of the kinetic constants
In order to get further insight into the process through which
colloids bind to the plasma membrane, we took advantage of
thoroughly quantifying the adhesion kinetics. These studies were
performed at 4 °C in order to distinguish the binding at the surface
from any process, such as endocytosis. As mentioned above, the shape
of the kinetic curves giving the amount of bound colloids as a functiong/mL of ﬂuorescent spherulites functionalized with Shiga toxin B-subunit (STxB): (a)
view in insert); (c) Suspended HeLa cells previously treated with an inhibitor of Gb3
se contrast image (and closer view in insert); (d) Confocal equatorial cut of suspended
ized colloids on untreated cell (not shown) is even lower than image c. Scale bars=15 μm.
Fig. 2. Quantiﬁcation of the speciﬁcity. A 0.3 mg/mL solution of ﬂuorescent colloids is
added to 106/mL HeLa cells. (a) Mean ﬂuorescence obtained by ﬂow cytometry on a
population of 10,000 cells after 200 min. Comparison is shown between non-
functionalized colloids at 4 °C (“No Ligand”) and STxB-colloids (“4 °C” and “37 °C”) on
normal cells and the case of PPMP-treated cells with STxB-colloids at 4 °C (“No
receptor”). (b) Complete kinetics corresponding to normal HeLa cells at 4 °C with STxB-
colloids (●), normal HeLa cells with non-functionalized colloids (□) and PPMP-treated
cells with STxB-colloids (▲). The background ﬂuorescence (intensity measured at time
of contact) was subtracted.
Fig. 3. Effect of colloid concentration on the kinetics of binding of STxB-colloids on Gb3
expressing HeLa cells at 4 °C. Mean ﬂuorescence intensity versus time for different
colloid concentrations. The background ﬂuorescence (intensity measured at time of
contact) was subtracted. Data are ﬁtted with I(t)= I0+(Isat− I0)(1−exp(−t/τ)). From top to
bottom, concentrations of spherulites are respectively: 1 mg/mL (◯), 0.7 mg/mL (●),
0.3 mg/mL (-), 0.2 mg/mL (△), 0.1 mg/mL (■) and 0.02 mg/mL (w). The variation of the
saturation value Isat and the characteristic time τ with colloidal concentration are
shown on Fig. 4.
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form I(t)= I0+(Isat− I0)(1−exp(−t/τ)), where I0 is the initial or back-
ground ﬂuorescence, Isat is the saturation value, and τ is the
characteristic time. In order to test if this behavior corresponds to
an equilibrium situation (whether considered as a ligand/receptor
binding or as a particle/surface adsorption), and to be able to extract
the kinetic constants, cell samples were mixed with increasing
concentrations of STxB-colloids. As shown on Fig. 3, the data reveal
an increase of the saturation value with particle concentration and a
decrease in the characteristic time. The fact that the saturation value
adjusts itself to the bulk concentration suggests an equilibrium
situation, where the ﬁnal number of bound colloids results from the
balance between ongoing adsorption and desorption of particles.
Saturation is not due to the saturation of binding sites. From each
curve, both the equilibrium value and the characteristic time were
extracted using a ﬁt with the above exponential expression of I(t). The
value Isat of the saturation plateau, represented on Fig. 4a, shows a
linear dependence with colloid concentration, which is compatible
with a linear regime of a usual adsorption process. In the same way,
the inverse of the characteristic time 1/τ varies linearly with colloid
concentration as seen on Fig. 4b. From these data, assuming for the
moment a simple one-step equilibrium model where a free colloidbinds reversibly to a surface binding site (no matter how many
receptors are involved), one can deduce k1 and k2, the respective
kinetic constants for the adsorption and the desorption of the particle.
Deriving simple equilibrium equations and mass conservation laws,
the characteristic times are known to vary according to 1/τ=k1C+k2, and
the saturation value Isat is proportional to RTC/(C + KD), where RT is the
total number of binding sites and C the colloid bulk concentration (which
is considered to remain constant during the experiment, the amount of
bound particles being negligible). From the linear ﬁt, kinetic constants k1
and k2 can be estimated to be and k1=8.4(±0.7)×104s−1 M−1 and k2=3.25
(±0.1)×10−4s−1. The thermodynamic constant KD, deﬁned as the ratio k1/
k2 is then found equal to 3.9(±0.5) nM, which suggests a strong afﬁnity
between colloids and cells.
In the case of the saturation, we only observe the linear regime
because of the limited concentration range that was used in these
studies. As saturation is reached within a few hours, we can also
determine the equilibrium constant by measuring saturation values
for a wider range of particle concentrations. The graph of Fig. 4c
describes experimental data obtained after 4.5 h of contact between
colloids and cells. The number of bound colloids ﬁrst increases with
the bulk concentration and then becomes independent from con-
centration above a critical value. These observations are compatible
with the hyperbolic expression of Isat for a classical equilibrium
mentioned above. This allows us to have anotherway to determine the
equilibrium constant KD, which is evaluated here as KD=1.5(±0.4) nM.
The two values are in good agreement. The interaction between STxB-
colloids and HeLa cells can thus be modeled so far by a classical
adsorption equilibriumwith an apparent afﬁnity constant of a few nM.
These units must be understood as a number of spherulites per
volume, using the average diameter to convert the lipid mass into a
concentration of particles. A simple geometrical consideration shows
that approximately 6000 STxB units are present at the surface of one
particle. This estimation allows expressing the particle concentration
in terms of equivalent toxin concentration. One ﬁnds an equivalent
toxin concentration of the order of 10 μM for the KD.
3.3. Equilibrium perturbations
According to the previous equilibrium hypothesis, the system
should adjust itself after a modiﬁcation of the bulk concentration.
Fig. 4. Determination of kinetic constants: (a) Fluorescence intensity on the plateau
Isat versus colloid concentration in the linear regime for values of C lower than KD.
The concentration is expressed in terms of number of particles per volume (M),
which is deduced from the value in mg/mL by assuming a monodisperse size for the
particles (R∼100 nm). (b) Inverse of characteristic time 1/τ (s−1) versus colloid
concentration. The ﬁt of the form 1/τ=k1C+k2 gives k1=8.4(±0.7) ×104 s−1 M−1 and
k2=3.25(±0.1)×10−4 s−1 and KD=3.9(±0.5) nM. (c) Asymptotic ﬂuorescence intensity
on a broader range of colloid concentrations, directly measured after 4 h 30min of contact
between particles and cells. The ﬁt of the form RTC/(C+KD) gives KD=1.5(±0.4) nM.
Fig. 5. Equilibrium perturbations for STxB-colloids: Fluorescence intensity versus time
for 0.1 mg/mL (◯) and 0.3 mg/mL (●). At t=200 min, the sample is either diluted by a
factor 3 (□) or concentration is increased from 0.1 to 0.3 mg/mL (▲). The ﬂuorescence
remains unchanged during dilution whereas the saturation value adjusts to the bulk
concentration when new colloids are added. The lower dotted line represents the
typical decrease expected for a reversible adsorption.
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decreased or increased after the equilibriumplateau had been reached.
Cells were incubated with two different concentrations of colloids (for
example 0.1 mg/mL and 0.3 mg/mL as shown on Fig. 5), and the
adhesion kinetics were recorded. At the indicated times, samples were
diluted by a factor of 3 (Fig. 5). We observed that ﬂuorescence remains
constant (empty square), as opposed to the expected dissociation
proﬁle (decreasing dotted line). This observation strongly differs from
the case of non-speciﬁc electrostatic interactions involving cationic
spherulites, in the case of which desorption was observed [20].
Moreover, these features were observed independently of the time ofdilution, initial concentration values, and dilution factors. Competition
is an alternative method to induce desorption. Once equilibrium had
been reached, a high concentration of free STxB ligands was added to
the mixture of colloids and cells as competitors. Just as in the case of
dilution, no effect on cell associated ﬂuorescence was observed. In the
same manner, if the sample was rinsed and the whole solution was
replaced with unlabeled spherulites at the same concentration, no
desorption was measured either. These results indicate that STxB-
spherulites cannot dissociate from cells once ligand/receptor interac-
tions have been formed, i.e. that particles are irreversibly bound to the
membrane. At ﬁrst, this result apparently contradicts the equilibrium
hypothesis, which necessarily implies possible dissociation of colloids.
Now if wewere to consider the scenario of irreversible cell binding,
whether the irreversible step happens at early stage or later on
through endocytosis or fusion, the existence of a plateau would
suggest that receptors are saturated. However, what we observe
experimentally is that an addition of colloids in the bulk once cells
have reached the plateau gives rise to an increase in the ﬂuorescence
intensity to the value expected for the new bulk concentration. Fig. 5
illustrates the example of a sample in which STxB-spherulite
concentration increased from 0.1 to 0.3 mg/mL. These data demon-
strate that new colloids adhere on the membrane and that free
receptors are still available. We are thus left with a situation in which
the system is able to adjust itself as expected from a reversible
equilibrium, but with particles that are bound irreversibly.
3.4. Comparison with free STxB ligand
To test whether a similar apparent contradiction was observed in
the case of free molecules as well, binding of free STxB ligands to
cells was analyzed. Using ﬂuorescent labeled STxB ligands and cells
which do or do not express Gb3, the interaction was ﬁrst proved to
be speciﬁc. Then, as in the case of colloids, the thermodynamic and
kinetic constants of the interaction with cells were determined by
ﬂow cytometry. Similarly, an exponential increase and a plateau
whose value depends on the initial ligand concentration were
measured. The characteristic times were approximately one order
of magnitude smaller than for colloids. Fig. 6a shows two adsorption
curves corresponding to 10 nM and 200 nM of STxB, and data
measured when STxB concentration is increased from 10 to 200 nM
at t=120 min. We can see that the saturation value adjusts to the
bulk concentration. By measuring the saturation value after 75 min of
incubation for concentrations of ligand ranging from 1 nM to 1 μM
(data not shown), the thermodynamic constant KD was extracted
Fig. 6. Binding and desorption of free ﬂuorescent STxB on HeLa cells. (a) Fluorescence
intensity versus time for a solution of 10 nM (▲) and 200 nM (●) and when
concentration is increased from 10 to 200 nM at t=120 min (◯). The saturation value
adjusts to the bulk concentration. (b) Fluorescence intensity versus time for a solution of
75 nM (●) and 150 nM (▲) (both above the KD) and after the addition of non-ﬂuorescent
STxB at t=120min (◯) to a total ﬁnal concentration of 150 nM. The exponential decrease
(dotted line) indicates that ﬂuorescent and non-ﬂuorescent STxB are being exchanged
at the membrane surface.
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kinetic constants kon and koff were calculated from the complete
kinetics analysis and found to be and kon=6.6(±0.4)×104 s−1 M−1 and
koff=2.3(±0.3)×10−3 s−1, which in turn led to another estimation of
the thermodynamic dissociation constant KD equal to 35(±8) nM.
These two estimations are in good agreement to the value (46 nM)
reported by Head et al. [28] in a microplate assay. The value of the
free toxin KD is more than 2 orders of magnitude lower than
the equivalent toxin concentration estimated for the spherulites KD
(10 μM, see above). This reﬂects the fact that, in the case of particles,
only a very small amount of the proteins are actually involved in the
osmotic pressure, because only a small fraction of the surface of
bound particles faces towards the membrane (see below for further
discussion).
As opposed to the situation involving STxB-spherulites, we
observed desorption of bound STxB ligands when performing dilution
or competition experiments. To demonstrate this, non-ﬂuorescent
STxB was added on cells initially incubated for 2 h with 75 nM
ﬂuorescent STxB. As shown on Fig. 6b, an exponential decrease of the
cell ﬂuorescence of the order of half the plateau value was observed,
indicating that ﬂuorescent and non-ﬂuorescent STxB are freely
exchanging on the membrane. This ﬁnding directly demonstratesthat the system reacts as expected for classical ligand–receptor
equilibrium: saturation value increases with the volume fraction of
ligands and dissociation is possible.
4. Discussion and conclusion
As shown experimentally, the speciﬁc adhesion of STxB-functio-
nalized colloids on HeLa cells presents an intriguing behavior whose
main features can be summarized as follows: i) the amount of bound
colloids reaches saturation with time and the saturation value
depends on the bulk colloid concentration; ii) once bound, colloids
do not dissociate; iii) when bulk concentration is increased after
saturation, more colloids are still able to bind. The ﬁrst feature is
reminiscent of an equilibrium process whereas the second reﬂects
irreversibility. The third underlines the presence of available receptors
in the membrane even after saturation. The case of a simple
equilibrium adsorption can be excluded because the dissociation
timescale would be of the order of magnitude of the adsorption one,
which is not compatible with the absence of dissociation. The case of
an irreversible step occurring at some stage of the process, such as
endocytosis or fusion, should also be excluded. This would lead to a
unique saturation value for any bulk concentration, the only difference
being the timescale to reach this plateau. The plateau would occur
when all receptors are occupied and they would not be free to
welcome additional colloids when concentration is increased.
To explain our observations, we thus need to take into account the
possibility for particles to interact with several receptors, and the fact
that receptors freely diffuse. Structural considerations have shown
that one STxB pentamer may bind up to 15 Gb3 molecules [29–31].
While the colloids, which are Brownian particles, are bouncing
towards the membrane, Gb3 receptors can interact with a ligand
present either on a newly arriving particle, either on an already
docked particle. Therefore, in addition to the favorable binding energy,
both the entropy of the receptors and the entropy of the colloids,
which will promote a balance between bound and free species, are
expected to drive the system towards equilibrium (or saturation).
With this in mind, the apparent contradiction between the evolution
of the plateau with concentration and the irreversibility can be
interpreted as the consequence of amultiple step process. This process
couples an initial stage where a particle binds reversibly to a ﬁrst
group of receptors with a later stage when neighboring receptors
diffuse towards the attachment zone to further tighten the link. The
ﬁrst step mainly depends on the diffusion coefﬁcient and concentra-
tion of colloids while the following steps are governed by kinetic
constants corresponding to the diffusion of receptors within the cell
membrane. Even though each step can be described in terms of
equilibrium, thus allowing bond dissociation at any time, yet the
apparent irreversibility derives from the necessity to unbind a great
number of links before releasing the particle. This leads to very
different characteristic times for binding and dissociation.
We notice that the KD value of the functionalized spherulites is
more than an order of magnitude lower than free STxB ligands (or 2
orders higher when expressed in equivalent toxin concentration).
Even though it is tempting at this point to relate the apparent KD of
colloids and the KD of free toxin, they are not simply connected. The
situation is different in many respects, be it on the side of the binding
energy or on the side of the entropy. Indeed, in the case of particles,
the diffusion and binding probability (these two ingredients under-
lying a KD) concerns the particle itself and several bonds participate in
the binding energy. It is only when it is docked on the surface that the
diffusion of STxB comes into play. At this point it is the local surface
density of STxB in the membrane rather than its overall bulk
concentration that participates in the entropy and only a small
fraction of ligands are concerned. We see that a complete description
must integrate the varying density of ligands and receptors on colloids
and cells together with their diffusion in the respective membranes.
2456 C. Poirier et al. / Biochimica et Biophysica Acta 1778 (2008) 2450–2457Some theoretical models have speciﬁcally addressed the question of
colloids interacting with membranes through ligand–receptor interac-
tions. Tzlil et al. [32] have presented a simple statistical thermodynamic
model for budding of viral nucleocapsids at the cell membrane. These
authors pointed to the interplay between the bending energy of the
membrane and the density of linkers. With a similar approach, van
Effenterre and Roux [33] derived a relationship between numbers of
bound colloids and bulk concentration, and showed competition
effects of colloids formobile receptors. Although the kinetics of binding
are not directly analyzed as such, thismodel predicts a transition froma
regime where colloids are tightly bound to a regime where they are
reversibly bound when bulk concentration is increased. Even though
this transition has not been observed in our experiments, yet the ﬁrst
regime can describe our situation as it is an equilibrium model with
reversible links. The large time spent by the colloid on the surface
results from the very weak probability to unbind all links at once.
Nevertheless, more sophisticated kineticsmodels togetherwith amore
detailed comparison between experiments and models are necessary
to validate our interpretation. Simplifying the system is another way to
get further insights: inspired by these experiments on real cells, we
began to study the interaction of STxB-spherulites with a biomimetic
system consisting of giant vesicles bearing Gb3 receptors. We found
very similar results and could easily vary the receptor density which
appeared to affect the reversibility [34].
Because the size of a particle can be large at the scale of receptors, it
should be noticed that many features of our system are similar to
classical cell adhesion. The diffusion of receptors in themembrane and
the multiplicity of binding sites are indeed known to drive cell
attachment and cell movement on a substrate [11,13]. In order for the
cell to adhere and move, afﬁnity must not be too high, but such low
afﬁnity has to be coupled with parallel binding of multiple receptors.
The main difference here lies in the fact that the surface in contact
with the cell is itself submitted to Brownian motion because particles
are still sufﬁciently small. In our experiments, this coupling between
the physics of cell adhesion and the physics of colloids is directly
evidenced on living cells. This coupling could also have consequences
in virology. In many cases virus infects a cell using protein receptors,
such as CD21 for EBV and CD4 for HIV. Even though the presentation of
protein receptors on the plasma membrane may differ from those of
glycolipid receptors, we could imagine that viruses behave in the same
fashion under certain circumstances because this mechanism does not
depend intrinsically on the nature of the interaction itself. However
the range of parameters (virus concentration, receptor density) for
which this behavior could occur might depend severely on binding
afﬁnity and thus be narrow. One key element being the interplay
between the high amount of lipid receptors, allowing cooperativity
(leading to irreversibility) and the low afﬁnity of a single binding site
allowing exchange (leading to equilibrium), it would be necessary to
have a similar balance in order to observe the same behavior for
another system.
As a conclusion, by coupling two promising entities in terms of
therapeutic applications, we have built up a new efﬁcient targeting
carrier for drug delivery, namely STxB-spherulites, demonstrated its
efﬁciency and speciﬁcity on cells, and proposed to use this
composition as a model to study colloid/cell interaction. Moreover,
we have developed an accurate statistical method using ﬂow
cytometry to quantify colloid binding, and revealed that microscopic
mechanisms could be deduced from thermodynamics and kinetics
studies. In this particular case, we pointed out the role of receptor
diffusion and multiple binding. On a more general level, the
methodology used in this article, based on direct quantitative
measurements on living cells focusing on the adhesion step, might
inspire new ways to test and optimize in situ drug delivery carrier
systems and to better quantify virus infection at the cellular level
without integrating the complex machinery of the intracellular
processes.Acknowledgements
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